In phase 1 it worked with 44% of patients it seems, it's multisite, it could be worth trying for our warrior with mCRPC (metastatic castrate resistant prostate cancer)
Phase 2 trial recruiting: revert horm... - Advanced Prostate...
Phase 2 trial recruiting: revert hormone resistance with apalutamide and ENV105
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
new trial for mCRPCa: ²²⁵Ac-rhPSMA-10.1 actinium
"The trial will enrol male patients with metastatic castrate-resistant prostate cancer who have...
177Lu-PSMA-617 versus docetaxel in chemotherapy-naïve mCRPC: a randomized, controlled, phase 2 non inferiority trial.
"177Lu-PSMA-617 was demonstrated to be safe and non-inferior to docetaxel in the treatment of mCRPC...
promising against soft tissue and bone metastasis: AMG 509
there might be hope!!...
Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant PCa with [161Tb]Tb-PSMA-I&T
and it's supposed to do a better job than Lutetium (Pluvicto)
But keep an eye also on 64 Cu SAR...
Aussies will save us all: from Oz, a molecule that can (could) treat resistant prostate cancer
They will need some time still...but...
"CDKI-73 is currently being investigated in Phase 2...
Related Posts
Veru Reports Positive Clinical Results from VERU-111 Phase 1b/2 Trial in Men with Metastatic Castration-Resistant Prostate Cancer, Advancing
Starting Abiraterone and predniSONE
Discussion of Phase 2 trial with LU-177 PSMA-617- FDA Fast Track Designation for 225Ac-FL-020 for mCRPCa
Addition of Metformin after Progression on Abiraterone.
